RNA extraction

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

ZyGem said today that it has signed an OEM agreement with Saudi Diagnostics, which will market ZyGem's DNA and RNA extraction kits for a variety of research applications.

GSK gains certain rights to Response Genetics' PCR analysis technology and diagnostic expertise to assess BRAF mutations in human tumor samples.

The company already offers many of these services to customers in North America and Europe through Gaithersburg, Md.-based subsidiary Gene Logic.

ZyGem's method, available in a commercial kit, can prepare samples in under 20 minutes, or up to ten times faster than existing RNA extraction products; while Genomic Health's method can access the entire transcriptome from formalin-fixed, paraffin-embedded tissues for downstream analyses.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.